Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Delayed Nyse Other stock markets 04:00:01 2024-05-24 pm EDT			5-day change	1st Jan Change
584 ^USD	-0.17%		-1.89%	+10.03%

May. 24	Declaration of Voting Results by Thermo Fisher Scientific Inc	CI
May. 22	Thermo Fisher Scientific Keeps Quarterly Dividend of $0.39 a Share, Payable July 15 to Shareholders of Record on June 14	MT

Thermo Fisher Scientific Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024

April 24, 2024 at 06:00 am EDT

Thermo Fisher Scientific Inc. reported earnings results for the first quarter ended March 30, 2024. For the first quarter, the company reported sales was USD 10,345 million compared to USD 10,710 million a year ago. Net income was USD 1,328 million compared to USD 1,289 million a year ago.

Basic earnings per share from continuing operations was USD 3.47 compared to USD 3.34 a year ago. Diluted earnings per share from continuing operations was USD 3.46 compared to USD 3.32 a year ago.

Latest news about Thermo Fisher Scientific

Declaration of Voting Results by Thermo Fisher Scientific Inc	May. 24	CI
Thermo Fisher Scientific Keeps Quarterly Dividend of $0.39 a Share, Payable July 15 to Shareholders of Record on June 14	May. 22	MT
Thermo Fisher Scientific Introduces Array-Based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions	May. 15	CI
Transcript : Thermo Fisher Scientific Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM	May. 14
UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger	May. 10	MT
UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink	May. 10	MT
UK's CMA kicks off probe into Thermo Fisher-Olink deal	May. 10	RE
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	May. 07	RE
Thermo Fisher Scientific Insider Sold Shares Worth $5,737,356, According to a Recent SEC Filing	May. 02	MT
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $600 From $540	May. 01	MT
Thermo Fisher Scientific Insider Sold Shares Worth $1,135,880, According to a Recent SEC Filing	Apr. 29	MT
HSBC Raises Thermo Fisher Scientific's Price Target to $670 From $660	Apr. 29	MT
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	Apr. 29	MT
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	Apr. 29	CI
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating	Apr. 29	MT
Redburn Atlantic Adjusts Price Target on Thermo Fisher Scientific to $620 From $615	Apr. 26	MT
Deutsche Bank Adjusts Price Target on Thermo Fisher Scientific to $610 From $600	Apr. 25	MT
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $648 From $644	Apr. 25	MT
Bernstein Adjusts Thermo Fisher Scientific Price Target to $553 From $544	Apr. 25	MT
JPMorgan Adjusts Thermo Fisher Scientific Price Target to $650 From $600	Apr. 25	MT
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $650 From $620, Keeps Overweight Rating	Apr. 25	MT
Stifel Adjusts Price Target on Thermo Fisher Scientific to $600 From $595	Apr. 25	MT
Goldman Sachs Adjusts Price Target on Thermo Fisher Scientific to $650 From $640	Apr. 25	MT
Barclays Adjusts Price Target on Thermo Fisher Scientific to $615 From $590	Apr. 25	MT
RBC Adjusts Price Target on Thermo Fisher Scientific to $662 From $657	Apr. 25	MT

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-23 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

584 USD

Average target price

627.5 USD

Spread / Average Target

+7.43%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	195B
INTUITIVE SURGICAL, INC.	+20.01%	144B
BOSTON SCIENTIFIC CORPORATION	+30.83%	111B
SIEMENS HEALTHINEERS AG	+2.28%	65.01B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	53.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.64%	50.45B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.15B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.45B
RESMED, INC.	+23.97%	31.33B

Other Advanced Medical Equipment & Technology